Metabolic-Fit / 100
Kina review
A menopause clinic that treats GLP-1 weight care as a menopause problem, which almost nothing else on this roster does. Four routes are published with prices attached: semaglutide injection at $199 a month, semaglutide dissolving tablets at $279, tirzepatide injection at $249 and tirzepatide sublingual drops at $229, flat at every dose, with anti-nausea support included free for the first two months. The catch is a real one and it is not hidden in the small print so much as split across two pages. The weight page promises no membership and one all-in price; the Terms you actually agree to describe membership plans, recurring charges, and medication billed separately on top. Get which one applies to you in writing before you subscribe.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Kina at a glance
- Semaglutide
- $199/mo injection ($279/mo oral tablet)
- Tirzepatide
- $229/mo sublingual ($249/mo injection)
- Coverage
- Does not disclose — availability is described only as varying by state
- Brand-name
- Compounded only
How we scored Kina
Every factor comes from Kina's own published pricing, disclosures and oversight, and the six combine into the 54/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.trykina.com/weight
$199 for the semaglutide injection and $279 for the oral tablet; $249 for tirzepatide injectable and $229 sublingual, after a $169 first month — the whole ladder in one sentence, at the same price for every dose, with anti-nausea medication free for two months. Read the Terms: membership fees are non-refundable once a clinician has reviewed you.
What to expect when you sign up
We walked Kina's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on trykina.com (https://www.trykina.com/weight)
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Flex Dose injection, weekly — same price at every doseOngoing rate. $169 covers the first month only. Described as monthly; no four-week or 28-day language appears on the site. |
| Compounded semaglutide | $279 | ODT dissolving tablet, daily, with anti-nausea included |
| Compounded tirzepatide | $249 | Injection, weekly — same price at every dose |
| Compounded tirzepatide | $229 | Sublingual drops, once daily |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Kina's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Genuinely menopause-first — the weight care is framed around hormonal change rather than bolted onto a general weight clinic
- Four delivery routes published with prices: two semaglutide, two tirzepatide, including sublingual drops and dissolving tablets
- Flat pricing at every dose on all four, stated plainly as 'same price at every dose, no surprise increases'
- Zofran anti-nausea support included free for the first two months
- The clinical group is named outright — Arora Health & Aesthetics, LLC in Seattle — with a compliance contact, which most of this roster does not do
- Prices sit on the open weight page rather than behind the intake quiz
- No FDA warning letter against the brand, the operator or the named clinical group
The caveats
- Its own pages contradict each other on the central question: the weight page says '$0 membership or hidden fees, ever' while the Terms describe membership plans, recurring charges, and medication 'billed separately'
- The Terms are what you legally attest to, and they say membership fees are non-refundable once a clinician has reviewed your intake
- Shipped medication orders are non-refundable under the same clause
- Its own site footer advertises 'Starting at $169/mo' — that is a first-month rate carrying a monthly suffix, and the ongoing price is $199
- A separate pricing page quotes a membership at $39 for the first month and $59 a month after, which appears nowhere on the weight page
- Three different entities appear across the site: Kina Health, Inc. in the Terms, Stewart Ventures Inc. in the footer copyright, and Arora Health & Aesthetics, LLC as the treating group
- States served are never published — availability is described only as varying by state
- No postpartum, breastfeeding or PCOS guidance anywhere on its weight page or FAQ, which is a real gap for a clinic built around women's hormones
Kina for mothers: our verdict
A menopause clinic that treats GLP-1 weight care as a menopause problem, which almost nothing else on this roster does. Four routes are published with prices attached: semaglutide injection at $199 a month, semaglutide dissolving tablets at $279, tirzepatide injection at $249 and tirzepatide sublingual drops at $229, flat at every dose, with anti-nausea support included free for the first two months. The catch is a real one and it is not hidden in the small print so much as split across two pages. The weight page promises no membership and one all-in price; the Terms you actually agree to describe membership plans, recurring charges, and medication billed separately on top. Get which one applies to you in writing before you subscribe. It runs about $199/month, flat across every dose.
We weigh Kina the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Kina costs, in full
- Compounded semaglutide — Flex Dose injection, weekly — same price at every dose: $199/mo
- Compounded semaglutide — ODT dissolving tablet, daily, with anti-nausea included: $279/mo
- Compounded tirzepatide — Injection, weekly — same price at every dose: $249/mo
- Compounded tirzepatide — Sublingual drops, once daily: $229/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
Kina says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Kina prescribes
Kina prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Kina fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Kina is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A woman in perimenopause or menopause who wants weight care from clinicians who treat that as the cause, and who will confirm the membership question before paying.
Alternatives to Kina
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Kina
Head-to-head & alternatives
Kina, answered
- How much does Kina cost?
- At last review, Kina's lowest ongoing compounded rate was about $199 a month — $199/mo injection ($279/mo oral tablet) for semaglutide, $229/mo sublingual ($249/mo injection) for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Kina safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Kina is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Kina offer both semaglutide and tirzepatide?
- Yes — Kina offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Kina rank for mothers?
- Kina scores 54/100 on our Metabolic-Fit Score and sits at #48. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Kina's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.